ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,648.21
0.30%
Dow Jones
40,776.72
1.41%
US Dollar vs MXN
17.6914
-0.22%
Brent Oil
83.475
-1.03%
Bitcoin
64,406.05
-0.69%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Compugen Ltd (CGEN)

  7. Compugen Ltd (CGEN) Noticias

CGEN

Compugen (CGEN)

Compugen Ltd
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:CGEN
FechaHoraFuenteTítuloSímboloCompañía
23/12/200907:22Dow Jones NewsCompugen Rallies As It Reaches Research Deal With PfizerNASDAQ:CGENCompugen Ltd
23/12/200906:04Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:CGENCompugen Ltd
23/12/200906:00Business WireCompugen Announces “Discovery on Demand” Therapeutic Peptide Collaboration with PfizerNASDAQ:CGENCompugen Ltd
09/11/200906:00Business WireCompugen Announces Discovery of Genetic Biomarker for Predisposition to Type 2 DiabetesNASDAQ:CGENCompugen Ltd
05/11/200906:00Business WireCompugen Announces Preeclampsia Biomarker CollaborationNASDAQ:CGENCompugen Ltd
30/10/200915:18Edgar (US Regulatory)Prospectus filed pursuant to Rule 424(b)(5) (424B5)NASDAQ:CGENCompugen Ltd
27/10/200906:00Business WireCompugen Reports Third Quarter 2009 Financial ResultsNASDAQ:CGENCompugen Ltd
26/10/200906:00Business WireCompugen Presents DAC Blockers Platform and Initial Product Candidates at Fifth Peptide Engineering Meeting in Barcelona, SpainNASDAQ:CGENCompugen Ltd
20/10/200906:00Business WireCompugen Ltd. to Review Third Quarter 2009 Results on Tuesday, October 27, 2009NASDAQ:CGENCompugen Ltd
13/10/200906:00Business WireCompugen and Bayer Schering Pharma to Collaborate on Compugen Discovered Oncology Target and Splice VariantsNASDAQ:CGENCompugen Ltd
11/08/200911:51Edgar (US Regulatory)Securities Registration (foreign private issuer) (F-3/A)NASDAQ:CGENCompugen Ltd
11/08/200907:38Edgar (US Regulatory)Securities Registration (foreign private issuer) (F-3)NASDAQ:CGENCompugen Ltd
28/07/200906:00Business WireCompugen Reports Second Quarter 2009 ResultsNASDAQ:CGENCompugen Ltd
21/07/200906:00Business WireCompugen Announces Positive Therapeutic Effects of Novel Peptide in Animal Model of RetinopathyNASDAQ:CGENCompugen Ltd
20/07/200906:00Business WireCompugen Ltd. to Review Second Quarter 2009 Financial Results on Tuesday, July 28, 2009NASDAQ:CGENCompugen Ltd
20/07/200905:05Edgar (US Regulatory)Amended Statement of Beneficial Ownership (SC 13D/A)NASDAQ:CGENCompugen Ltd
30/06/200905:00Business WireCompugen Reports Sale of a Portion of Its Evogene HoldingsNASDAQ:CGENCompugen Ltd
24/06/200908:00MarketwiredStocks to Watch for Wednesday, June 24, 2009: ARYC -- Arrayit Corporation to Enter Molecular Diagnostics Using VIP(TM) TechnologNASDAQ:CGENCompugen Ltd
24/06/200906:00Business WireCompugen Announces Additional Grants from Israel Office of Chief Scientist for Validation Studies of Therapeutic CandidatesNASDAQ:CGENCompugen Ltd
23/06/200906:00Business WireCompugen Announces Positive Therapeutic Effects of Novel Peptide in Animal Model of Inflammatory Bowel DiseaseNASDAQ:CGENCompugen Ltd
17/06/200906:00Business WireCompugen Transfers to The NASDAQ Capital MarketNASDAQ:CGENCompugen Ltd
02/06/200907:00Business WireCompugen Receives Deficiency Letter from NASDAQ With Respect to Stockholders EquityNASDAQ:CGENCompugen Ltd
02/06/200905:00Business WireCompugen Appoints Dr. Anat Cohen-Dayag and Martin Gerstel as Co-CEOsNASDAQ:CGENCompugen Ltd
14/05/200906:00Business WireCompugen Announces In Vivo Confirmation of Cardiovascular Therapeutic Potential for Two Novel PeptidesNASDAQ:CGENCompugen Ltd
12/05/200906:00Business WireCompugen Reports First Quarter 2009 Financial ResultsNASDAQ:CGENCompugen Ltd
05/05/200902:11Business WireCompugen Ltd. to Review First Quarter 2009 Financial Results on Tuesday, May 12, 2009NASDAQ:CGENCompugen Ltd
29/04/200906:00Business WireCompugen Predictive Discovery Capabilities Presented by CTO at Bio-IT Conference and Expo 2009NASDAQ:CGENCompugen Ltd
01/04/200906:00Business WireCompugen Announces Inhibition of Angiogenesis by Novel PeptideNASDAQ:CGENCompugen Ltd
24/03/200906:00Business WireTeva to Utilize Compugen-Discovered Biomarkers for Pre-Clinical Detection of Drug-Induced Kidney ToxicityNASDAQ:CGENCompugen Ltd
18/03/200911:01Edgar (US Regulatory)Annual and Transition Report (foreign private issuer) (20-F)NASDAQ:CGENCompugen Ltd
 Showing the most relevant articles for your search:NASDAQ:CGEN

Su Consulta Reciente

FX
EURUSD
Euro vs US Dollar
CCOM
SILVER
SILVER
USOTC
BNPQY
BNP Paribas (QX)
USOTC
DTEGY
Deutsche Telekom (QX)
USOTC
BASFY
BASF (QX)
CCOM
US30
US 30
NYSE
VZ
Verizon Communications
NASDAQ
TSLA
Tesla
COIN
ETHUSD
Ethereum
AMEX
XLF
Financial Select Sector
AMEX
XLV
Health Care Select Sector
NASDAQ
MSFT
Microsoft
NYSE
MRK
Merck
NASDAQ
NVDA
NVIDIA
FX
USDMXN
US Dollar vs MXN
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados